Fang Ni

Fang Ni, Pharm.D, brings considerable experience in business development and corporate strategy in the life sciences sector. As Chief Business Officer, Fang is responsible for leading Black Diamond’s strategic and business development initiatives.

Prior to joining Black Diamond in 2020, Fang served as Principal and member of the investment team at Versant Ventures. He was Black Diamond’s founding Chief Business Officer following the Company’s Versant-led Series A financing, making critical contributions to Black Diamond’s corporate and business strategy. While at Versant, Fang also served as Interim Chief Business Officer for several new ventures, including Monte Rosa Therapeutics and Bright Peak Therapeutics. Prior to joining Versant, he was previously a Global Business Development & Licensing director within Roche’s Partnering organization, where he was responsible for leading transactions across the fields of oncology, immunology, and infectious and rare diseases.

Fang earned a Doctor of Pharmacy degree from Purdue University, and he then completed a post-doctoral fellowship at Rutgers University.